DekaBank Deutsche Girozentrale’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-16,000
| Closed | -$86K | – | 1102 |
|
|
2016
Q1 | $86K | Sell |
16,000
-1,300
| -8% | -$6.99K | ﹤0.01% | 981 |
|
|
2015
Q4 | $180K | Hold |
17,300
| – | – | ﹤0.01% | 888 |
|
|
2015
Q3 | $320K | Buy |
17,300
+600
| +4% | +$11.1K | ﹤0.01% | 778 |
|
|
2015
Q2 | $325K | Buy |
16,700
+600
| +4% | +$11.7K | ﹤0.01% | 790 |
|
|
2015
Q1 | $283K | Sell |
16,100
-2,300
| -13% | -$40.4K | ﹤0.01% | 828 |
|
|
2014
Q4 | $284K | Sell |
18,400
-1,700
| -8% | -$26.2K | ﹤0.01% | 803 |
|
|
2014
Q3 | $253K | Buy |
20,100
+500
| +3% | +$6.29K | ﹤0.01% | 778 |
|
|
2014
Q2 | $306K | Sell |
19,600
-1,300
| -6% | -$20.3K | ﹤0.01% | 699 |
|
|
2014
Q1 | $274K | Buy |
20,900
+2,100
| +11% | +$27.5K | ﹤0.01% | 673 |
|
|
2013
Q4 | $313K | Buy |
18,800
+400
| +2% | +$6.66K | 0.01% | 609 |
|
|
2013
Q3 | $306K | Buy |
+18,400
| New | +$306K | 0.01% | 600 |
|